https://www.taxtmi.com/news?id=65088 India's pharmaceutical export strategy emphasises trade liberalisation and regulatory strengthening to expand global market access, leveraging recent trade agreements with binding zero-tariff provisions. Key measures include addressing non-tariff barriers, expanding regulatory cooperation and mutual recognition to accelerate approvals, implementing the revised Good Manufacturing Practices framework, and building capacity in quality management, clinical research, biologics and digital compliance to support MSMEs and enhance export competitiveness. en-us Thu, 18 Dec 2025 09:28:17 +0530 Thu, 18 Dec 2025 09:28:16 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=65088 India's pharmaceutical export strategy emphasises trade liberalisation and regulatory strengthening to expand global market access, leveraging recent trade agreements with binding zero-tariff provisions. Key measures include addressing non-tariff barriers, expanding regulatory cooperation and mutual recognition to accelerate approvals, implementing the revised Good Manufacturing Practices framework, and building capacity in quality management, clinical research, biologics and digital compliance to support MSMEs and enhance export competitiveness. News - Thu, 18 Dec 2025 09:28:17 +0530 https://www.taxtmi.com/news?id=65088